Mariner
HZNP

Mariner’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Mariner’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15,781
Closed -$1.83M – 3236
2023
Q3 		$1.83M Sell
15,781
-50,285
-76% -$5.4M ﹤0.01% 1013
2023
Q2 		$6.79M Sell
66,066
-12,240
-16% -$1.29M 0.02% 546
2023
Q1 		$8.55M Sell
78,306
-1,033
-1% -$114K 0.02% 479
2022
Q4 		$9.03M Sell
79,339
-12,233
-13% -$1.02M 0.03% 435
2022
Q3 		$5.67M Buy
91,572
+3,240
+4% +$226K 0.02% 473
2022
Q2 		$7.05M Sell
88,332
-6,592
-7% -$624K 0.03% 401
2022
Q1 		$9.99M Sell
94,924
-2,655
-3% -$259K 0.04% 341
2021
Q4 		$10.5M Buy
97,579
+1,522
+2% +$166K 0.04% 299
2021
Q3 		$10.5M Buy
96,057
+16,305
+20% +$1.69M 0.05% 271
2021
Q2 		$7.47M Buy
79,752
+233
+0.3% +$21.4K 0.05% 272
2021
Q1 		$7.32M Buy
79,519
+58,608
+280% +$4.95M 0.05% 254
2020
Q4 		$1.53M Buy
+20,911
New +$1.55M 0.01% 481

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mariner's HZNP Position: Q4 2023 in Review

Mariner sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 15,781 shares — an estimated $1.83M sold.

Mariner first reported a position in HZNP in Q4 2020 and held it in 12 quarters. The position peaked at $10.5M in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Mariner reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Mariner sold 15,781 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.83M.
  • Mariner first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 12 quarters.
  • Mariner's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $10.5M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Mariner's 13F filing for Q4 2023, filed 14 Feb 2024.